Exome-wide association study of levodopa-induced dyskinesia in Parkinson’s disease

Exome-wide association study of levodopa-induced dyskinesia in Parkinson’s disease

Abstract Levodopa is the standard long-term dopamine replacement therapy to treat Parkinson’s disease (PD) symptoms. With time, levodopa may induce debilitating dyskinesias (LID), the treatment of which represents a large clinically unmet need. However, time-to-LID onset varies between patients, ref...

Descripció completa

Dades bibliogràfiques
Autors principals: Eva König, Alessandra Nicoletti, Cristian Pattaro, Grazia Annesi, Roberto Melotti, Alessandro Gialluisi, Christine Schwienbacher, Anne Picard, Hagen Blankenburg, Irene Pichler, Nicola Modugno, Marina Ciullo, Teresa Esposito, Francisco S. Domingues, Andrew A. Hicks, Mario Zappia, Peter P. Pramstaller
Format: Article
Idioma:English
Publicat: Nature Portfolio 2021-10-01
Col·lecció:Scientific Reports
Accés en línia:https://doi.org/10.1038/s41598-021-99393-8

Internet

https://doi.org/10.1038/s41598-021-99393-8

Ítems similars